Topical finasteride is finasteride applied to the scalp rather than swallowed. It targets DHT at the follicle with lower systemic exposure than the tablet, which is why men who want to avoid systemic side effects ask about it. HELiXVi prescribes finasteride inside compounded topical solutions, combined with minoxidil and other actives in a single daily application.
| Feature | Oral finasteride | Topical finasteride |
|---|---|---|
| FDA status | FDA-approved for male-pattern hair loss | Prescribed off-label, prepared by a compounding pharmacy |
| How you take it | A daily tablet | Applied to the scalp |
| Systemic exposure | Higher, the whole body sees the drug | Lower, most of the effect stays at the scalp |
| Evidence base | Large trials behind the approved tablet | Smaller studies, and growing |
| Who tends to ask for it | Men starting treatment | Men concerned about systemic side effects |
The evidence is smaller than for the tablet but points the same way: applying finasteride to the scalp lowers DHT at the follicle and slows androgenetic hair loss. What the studies do not show is that it outperforms the tablet. The case for it is exposure, not strength.
Route, and what reaches the rest of you. The tablet is FDA-approved and has the larger trial record behind it. A topical puts more of the drug where the problem is and less into circulation, which is the whole point for men worried about systemic effects. Your doctor weighs both against your history.
Yes, and most HELiXVi topical formulas already combine them. Minoxidil acts on the growth phase of the hair cycle and finasteride acts on DHT, so they address different parts of the problem rather than duplicating each other. One bottle also removes the two-step routine that people abandon.
Finasteride is included in several compounded solutions rather than sold on its own: Follicle Fix pairs it with minoxidil, Power Hair Solution adds progesterone, Power Hair Solution Plus adds tretinoin as well, Raven Solution adds vitamin E and fluocinolone for scalp irritation, and the Finasteride, Minoxidil and Tretinoin Solution combines all three. A licensed US doctor decides which suits you.
Finasteride is not FDA-approved for women and carries a pregnancy warning, so it is not prescribed to women who are pregnant or may become pregnant. Women with androgenetic thinning are more often prescribed minoxidil, spironolactone, or a compounded solution formulated for female-pattern hair loss.
Lower systemic exposure is the reason clinicians consider it, but safer is not the same as risk-free. Finasteride reaching the bloodstream at lower levels can still cause side effects, and the topical route is prescribed off-label. Raise any concerning symptom with your prescriber.
Yes. Every finasteride product requires a prescription in the United States, and compounded topical solutions are prepared by a state-licensed pharmacy on that prescription. HELiXVi's online assessment is reviewed by a licensed US doctor who decides whether it is appropriate.
Expect three to six months before visible change, the same as the tablet, and some early shedding as follicles move into a new growth cycle. Treatment works only while you continue it, so stopping usually means losing the hair it was maintaining.
No. The compounded solution is prepared for an individual patient by a state-licensed pharmacy and is not FDA-approved as formulated, even though finasteride itself is approved as an oral tablet. Your doctor weighs that when deciding what to prescribe.
It can. Reported effects include scalp irritation where it is applied, and because some finasteride reaches the bloodstream the systemic effects listed on the finasteride label remain possible. Some men report symptoms that persist after stopping.
Explore HELiXVi hair loss treatments
Assessed by a doctor. Dispensed by a licensed pharmacist. Dispatched within 24 hours of your consultation and payment.